FTC sues significant pharmacy gain professionals around insulin prices The company brought action towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of lifestyle-preserving insulin medicine. Previously this summer season, the business held prolonged negotiations with Steward around tips on https://charlievuusq.getblogs.net/63166099/the-smart-trick-of-healthcare-news-that-nobody-is-discussing